176 related articles for article (PubMed ID: 36833713)
1. Personalized Care for Patients with Cancer in the Precision-Medicine Era.
Lopes-Júnior LC; Veronez LC
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833713
[TBL] [Abstract][Full Text] [Related]
2. Precision medicine/personalized medicine: a critical analysis of movements in the transformation of biomedicine in the early 21st century.
Iriart JAB
Cad Saude Publica; 2019 Mar; 35(3):e00153118. PubMed ID: 30916181
[TBL] [Abstract][Full Text] [Related]
3. Personalized medicine in cancer: where are we today?
Turnbull AK
Future Oncol; 2015; 11(20):2795-8. PubMed ID: 26344657
[No Abstract] [Full Text] [Related]
4. Genetics of personalized medicine: cancer and rare diseases.
Alves ITS; Condinho M; Custódio S; Pereira BF; Fernandes R; Gonçalves V; da Costa PJ; Lacerda R; Marques AR; Martins-Dias P; Nogueira GR; Neves AR; Pinho P; Rodrigues R; Rolo E; Silva J; Travessa A; Leite RP; Sousa A; Romão L
Cell Oncol (Dordr); 2018 Jun; 41(3):335-341. PubMed ID: 29633150
[TBL] [Abstract][Full Text] [Related]
5. Personalized cancer medicine: are we there yet?
Lawler M; Selby P
Oncologist; 2013 Jun; 18(6):649-50. PubMed ID: 23814159
[TBL] [Abstract][Full Text] [Related]
6. [Prostate cancer in the era of precision medicine: a new horizon].
Nguyen-Ngoc T; Berthold D; Normand C
Rev Med Suisse; 2023 May; 19(827):950-956. PubMed ID: 37195108
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era.
Uhm JH; Porter AB
Mayo Clin Proc; 2017 Jun; 92(6):995-1004. PubMed ID: 28578786
[TBL] [Abstract][Full Text] [Related]
8. Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell.
Özdemir V; Arga KY; Aziz RK; Bayram M; Conley SN; Dandara C; Endrenyi L; Fisher E; Garvey CK; Hekim N; Kunej T; Şardaş S; Von Schomberg R; Yassin AS; Yılmaz G; Wang W
OMICS; 2020 Feb; 24(2):62-80. PubMed ID: 32027574
[TBL] [Abstract][Full Text] [Related]
9. Molecular Breast Cancer Imaging in the Era of Precision Medicine.
Muzahir S
AJR Am J Roentgenol; 2020 Dec; 215(6):1512-1519. PubMed ID: 33084364
[No Abstract] [Full Text] [Related]
10. The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review.
Vranic S; Gatalica Z
Acta Med Acad; 2021 Apr; 50(1):47-57. PubMed ID: 34075763
[TBL] [Abstract][Full Text] [Related]
11. Getting personal: Head and neck cancer management in the era of genomic medicine.
Birkeland AC; Uhlmann WR; Brenner JC; Shuman AG
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2250-8. PubMed ID: 25995036
[TBL] [Abstract][Full Text] [Related]
12. The forthcoming era of precision medicine.
Gamulin S
Acta Med Acad; 2016 Nov; 45(2):152-157. PubMed ID: 28000491
[TBL] [Abstract][Full Text] [Related]
13. Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine.
Powers B; Pal T; Laronga C
Surg Oncol Clin N Am; 2018 Jan; 27(1):1-22. PubMed ID: 29132555
[TBL] [Abstract][Full Text] [Related]
14. The coming era of precision medicine for intensive care.
Vincent JL
Crit Care; 2017 Dec; 21(Suppl 3):314. PubMed ID: 29297399
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Treatment of Breast Cancer in the Precision Medicine Era.
Yan J; Liu Z; Du S; Li J; Ma L; Li L
Methods Mol Biol; 2020; 2204():53-61. PubMed ID: 32710314
[TBL] [Abstract][Full Text] [Related]
16. [Next generation zebrafish-based drug discovery and precision medicine].
Tanaka T; Koiwa J
Nihon Yakurigaku Zasshi; 2019; 154(2):78-83. PubMed ID: 31406047
[TBL] [Abstract][Full Text] [Related]
17. Shift from protocol-based to personalized medicine in active surveillance: beginning of a new era.
Loeb S
BJU Int; 2017 Jul; 120(1):3-4. PubMed ID: 28621058
[No Abstract] [Full Text] [Related]
18. Personalized cancer medicine: next steps in the genomic era.
Derks S; Diosdado B
Cell Oncol (Dordr); 2015 Feb; 38(1):1-2. PubMed ID: 25720594
[No Abstract] [Full Text] [Related]
19. Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells - is a new era coming?
Okla K; Wertel I; Wawruszak A; Bobiński M; Kotarski J
Crit Rev Clin Lab Sci; 2018 Sep; 55(6):376-407. PubMed ID: 29927668
[TBL] [Abstract][Full Text] [Related]
20. Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision.
Sahakyan N; Haddad A; Richardson S; Forcha-Etieundem V; Christopher L; Alharbi H; Campbell R
Anticancer Agents Med Chem; 2017; 17(8):1033-1039. PubMed ID: 28042778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
